Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 3,169-3,180 of 4,306
Drug study icon
CompletedNCT00216580

Use of Risperidone Long Acting Injectable for Schizophrenia

This study is completed. It is testing use of Risperidone Long Acting Injectable for Schizophrenia.

Location not clearly listed
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 16 Years to 45 Years
Countries
Sponsor
Janssen Pharmaceutica N.V., Belgium
Condition
Schizophrenia
Drug study icon
CompletedNCT00420823

Taurine for Schizophrenia

This study is completed in Australia. It is testing taurine for Schizophrenia.

In Melbourne
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 25 Years
Countries
Australia
Sponsor
Melbourne Health
Condition
Schizophrenia
Drug study icon
CompletedNCT00645320

Ziprasidone for Schizophrenia

This study is completed in Brazil. It is testing ziprasidone for Schizophrenia.

Multiple locations, including RIO de Janeiro RJ
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 55 Years
Countries
Brazil
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Schizophrenia
Behavioral study icon
CompletedNCT01981356

Acceptance and Commitment Therapy for the Inpatient Treatment of Psychosis

This summary needs review. Please check the official study record and contact the research team for details.

In Palo Alto
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 99 Years
Countries
United States
Sponsor
VA Office of Research and Development
Condition
Schizophrenia
Behavioral study icon
CompletedNCT06509100

Altitudes: A Digital Intervention to Support Caregivers

This summary needs review. Please check the official study record and contact the research team for details.

In Chapel Hill
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 99 Years
Countries
United States
Sponsor
University of North Carolina, Chapel Hill
Condition
Schizophrenia
Other study type icon
CompletedNCT02321943

Anomalous Self-Experience in First Episode Psychosis - A Six-Year Follow-Up Study

This summary needs review. Please check the official study record and contact the research team for details.

In Brumunddal
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalA study where researchers collect information without assigning a treatment.From 18 Years to 65 Years
Countries
Norway
Sponsor
Sykehuset Innlandet HF
Condition
Schizophrenia
Drug study icon
CompletedNCT00095810

Aripiprazole in people with Psychosis Associated With Parkinson's Disease

This summary needs review. Please check the official study record and contact the research team for details.

In Albany
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugOver 50 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT01446328

Bergen Psychosis Project 2 - The Best Intro Study

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Innsbruck
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugOver 16 Years
Countries
Austria, Norway
Sponsor
Haukeland University Hospital
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.